{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:43:03Z","timestamp":1792896183744,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005625","name":"RSNA Research and Educational Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA252640"],"award-info":[{"award-number":["K08 CA252640"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.radonc.2025.111048","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T15:43:26Z","timestamp":1752853406000},"page":"111048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Evaluating risk factors for skeletal-related events among bone metastases from solid tumors"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1116-9752","authenticated-orcid":false,"given":"Justin","family":"Leu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2058-873X","authenticated-orcid":false,"given":"Lakshmi Rekha","family":"Narra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0889-6890","authenticated-orcid":false,"given":"Winston","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4877-8028","authenticated-orcid":false,"given":"Hiba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3915-8350","authenticated-orcid":false,"given":"John","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0275-6968","authenticated-orcid":false,"given":"Jonathan T.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Grassberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1386-1542","authenticated-orcid":false,"given":"Erin F.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111048_b0005","first-page":"18","article-title":"Quality of life issues in patients with bone metastases: a systematic review","volume":"32","author":"Rajeswaran","year":"2023","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2025.111048_b0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ctrv.2012.07.002","article-title":"Denosumab in patients with cancer and skeletal metastases: a systematic review and meta-analysis","volume":"39","author":"Peddi","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2025.111048_b0015","first-page":"3361","article-title":"Prediction of skeletal-related events in patients with non-small cell lung cancer","volume":"24","author":"Aiba","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2025.111048_b0020","doi-asserted-by":"crossref","unstructured":"Nakanishi K, Hijikata Y, Uchino K, et al. Predicting Skeletal-related Events Using SINS. Spine.:10.1097\/BRS.0000000000004983. doi:10.1097\/BRS.0000000000004983.","DOI":"10.1097\/BRS.0000000000004983"},{"key":"10.1016\/j.radonc.2025.111048_b0025","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jor.24660","article-title":"Fracture risk assessment and clinical decision making for patients with metastatic bone disease","volume":"38","author":"Damron","year":"2020","journal-title":"J Orthop Res"},{"key":"10.1016\/j.radonc.2025.111048_b0030","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.21037\/apm.2019.08.07","article-title":"Role of bone-modifying agents in advanced cancer","volume":"9","author":"Desautels","year":"2020","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.radonc.2025.111048_b0035","first-page":"9267","article-title":"Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study","volume":"30","author":"Diel","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2025.111048_b0040","article-title":"Concordance to National Comprehensive Cancer Network (NCCN) clinical practice guideline (GL) drug therapy recommendations for metastatic breast cancer: an analysis from the commercial managed care claims database PharMetrics (PM)","volume":"28(15_suppl):1032\u20131032","author":"Lepisto","year":"2010","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2025.111048_b0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.23.00753","article-title":"Prophylactic radiation therapy versus standard of care for patients with high-risk asymptomatic bone metastases: a multicenter, randomized phase II clinical trial","volume":"42","author":"Gillespie","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111048_b0050","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1186\/s12885-020-07591-w","article-title":"Early palliative radiation versus observation for high-risk asymptomatic or minimally symptomatic bone metastases: study protocol for a randomized controlled trial","volume":"20","author":"Rosen","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2025.111048_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbo.2018.01.004","article-title":"Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: a systematic review of the real world data","volume":"11","author":"Zhang","year":"2018","journal-title":"Journal of Bone Oncology"},{"key":"10.1016\/j.radonc.2025.111048_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2024.100603","article-title":"Incidence, risk factors, and survival of bone metastases and skeletal-related events in melanoma patients: a systematic review and quality assessment of 29 studies","volume":"46","author":"Shimizu","year":"2024","journal-title":"Journal of Bone Oncology"},{"key":"10.1016\/j.radonc.2025.111048_b0065","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/cncr.30505","article-title":"Factors predicting skeletal-related events in patients with bone metastatic castration-resistant prostate cancer","volume":"123","author":"Klaassen","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111048_b0070","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s10147-016-1075-9","article-title":"Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis","volume":"22","author":"Tsuda","year":"2017","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111048_b0075","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1634\/theoncologist.2015-0377","article-title":"Risk factors for developing skeletal-related events in breast cancer patients with bone metastases undergoing treatment with bone-modifying agents","volume":"21","author":"Tanaka","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2025.111048_b0080","doi-asserted-by":"crossref","first-page":"915","DOI":"10.6004\/jnccn.2020.7668","article-title":"Bone metastases, skeletal-related events, and survival in patients with metastatic non\u2013small cell lung cancer treated with immune checkpoint inhibitors","volume":"19","author":"Qin","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radonc.2025.111048_b0085","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s13277-015-3907-z","article-title":"Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases","volume":"37","author":"Ulas","year":"2016","journal-title":"Tumor Biol"},{"key":"10.1016\/j.radonc.2025.111048_b0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1009672031531","article-title":"Multi-state models: a review","volume":"5","author":"Hougaard","year":"1999","journal-title":"Lifetime Data Anal"},{"key":"10.1016\/j.radonc.2025.111048_b0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0962280208092301","article-title":"Multi-state models for the analysis of time-to-event data","volume":"18","author":"Meira-Machado","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.radonc.2025.111048_b0100","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"key":"10.1016\/j.radonc.2025.111048_b0105","doi-asserted-by":"crossref","unstructured":"Therneau TM. survival: Survival Analysis. Published online June 22, 2001:3.8-3. doi:10.32614\/CRAN.package.survival.","DOI":"10.32614\/CRAN.package.survival"},{"key":"10.1016\/j.radonc.2025.111048_b0110","unstructured":"Therneau T. A Package for Survival Analysis in R. Published online 2023. https:\/\/CRAN.R-project.org\/package=survival."},{"key":"10.1016\/j.radonc.2025.111048_b0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/pcan.2016.26","article-title":"Do skeletal-related events predict overall survival in men with metastatic castration-resistant prostate cancer?","volume":"19","author":"Howard","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.radonc.2025.111048_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2022.100423","article-title":"Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: a real-world machine learning approach","volume":"34","author":"Jacobson","year":"2022","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.radonc.2025.111048_b0125","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1007\/s11999-010-1326-4","article-title":"In brief: classifications in brief: mirels\u2019 classification: metastatic disease in long bones and impending pathologic fracture","volume":"468","author":"Jawad","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.radonc.2025.111048_b0130","doi-asserted-by":"crossref","unstructured":"Pockett R d., CasTELlano D, Mcewan P, Oglesby A, Barber B l., Chung K. The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain. European Journal of Cancer Care. 2010;19(6):755-760. doi:10.1111\/j.1365-2354.2009.01135.x.","DOI":"10.1111\/j.1365-2354.2009.01135.x"},{"key":"10.1016\/j.radonc.2025.111048_b0135","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.111048_b0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jso.27731","article-title":"Factors associated with skeletal-related events in patients with bone metastatic melanoma: a retrospective study of 481 patients","volume":"130","author":"Shimizu","year":"2024","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2025.111048_b0145","article-title":"Skeletal-Related Events in Renal Cell Carcinoma: Prediction With Alkaline Phosphatase (ALP), C-reactive Protein (CRP), Haemoglobin (Hb) and Erythrocyte Sedimentation Rate (ESR) (A.C.H.E.) Score for Risk Stratification","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.radonc.2025.111048_b0150","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1002\/ijc.32836","article-title":"Clinical value of serum bone resorption markers for predicting clinical outcomes after use of bone modifying agents in metastatic bone tumors: a prospective cohort study","volume":"146","author":"Urakawa","year":"2020","journal-title":"Int J Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025045529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:00:59Z","timestamp":1759521659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025045529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"alternative-id":["S0167814025045529"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111048","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating risk factors for skeletal-related events among bone metastases from solid tumors","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111048"}}